Lip GYH

• Incident thrombocytopenia and bleeding risk in elderly patients with atrial fibrillation on direct oral anticoagulants: insights from the ATHEROsclerosis in Atrial Fibrillation study 2025-01-17
  CONCLUSION: Patients developing thrombocytopenia have an increased risk of MB. Dynamic evaluation of platelet count during follow-up may provide better prognostic value than baseline assessment only.
  Danilo Menichelli
• Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry 2025-01-16
  CONCLUSIONS: History of stroke still represents a key risk factor in patients with AF. Patients who suffered more than 1 episodes of stroke had significantly worse prognosis and further efforts may be required to improve their clinical outcomes.
  Steven Ho Man Lam
• Sex differences in atrial fibrillation in India: Insights from the Kerala-AF registry 2025-01-16
  CONCLUSION: In this large AF cohort from India, male patients had a higher prevalence of ischaemic heart disease, smoking, and alcohol use, while female patients had a higher prevalence of valvular heart disease. MACE did not differ by sex, though bleeding was more common in males. Almost a quarter of patients were not anticoagulated despite […]
  Peter Calvert
• Later Is Not Always Better: Timing of Oral Anticoagulant Resumption After Endoscopic Procedures, Between New Data and Residual Uncertainties 2025-01-15
  No abstract
  Giulio Francesco Romiti
• Air quality and the risk of acute atrial fibrillation (EP-PARTICLES study): A nationwide study in Poland 2025-01-15
  CONCLUSIONS: Air pollution acts as a triggering factor and can be associated with acute AF hospitalisations. PM2.5 and NO2 have an impact on AF even at concentrations levels below WHO air quality guideline norms.
  Anna Kurasz
• Rethinking Stroke Prevention in Atrial Fibrillation: One Size Does not Fit All 2025-01-14
  No abstract
  Panteleimon E Papakonstantinou
• Blood Pressure Levels Within Target: Not Just Good Control But Excellent Control Over Time 2025-01-13
  No abstract
  Meng Li
• The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry 2025-01-13
  CONCLUSIONS: CAD was prevalent in patients with AF, and clinical phenotypes of CAD influenced outcomes in patients with AF, with a history of MI/unstable angina being associated with a significantly increased risk of CV events, compared to stable angina. NOACs were superior to VKA in terms of the effectiveness and safety outcomes in patients with […]
  Bi Huang
• Causes of death in patients with atrial fibrillation in the UK: a nationwide electronic health record study 2025-01-10
  AIMS: Causes of death remain largely unexplored in the atrial fibrillation (AF) population. We aimed to (i) thoroughly assess causes of death in patients with AF, especially those associated with sudden cardiac death (SCD) and (ii) evaluate the potential association between AF and SCD.
  Yongtong Lai
• Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials 2025-01-08
  CONCLUSIONS: Although the findings are limited by a small sample size, the results suggest that DOACs are safe with at least similar outcomes concerning LVT resolution and major bleeding compared with warfarin. (ClinicalTrials.gov: NCT05705089).
  Yaser Jenab
• Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015) 2025-01-06
  BACKGROUND: Insulin resistance (IR) is an important risk factor for multiple chronic diseases, increasing mortality and reducing life expectancy. The associations between emerging surrogates for IR, triglyceride-glucose index (TyG) and TyG-related indicators, with all-cause mortality and life expectancy in middle-aged and older patients in primary care are unclear.
  Yang Chen
• In HFpEF, semaglutide reduced a composite of worsening HF or CV death 2025-01-06
  GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
  Steven Ho Man Lam
• Thrombosis and Haemostasis 2024 Editors' Choice Papers 2025-01-03
  No abstract
  Christian Weber
• Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial 2024-12-31
  Adequate secondary prevention in survivors of intracerebral hemorrhage (ICH) who also have atrial fibrillation (AF) is a long-standing clinical dilemma because these patients are at increased risk of recurrent ICH as well as of ischemic stroke. The efficacy and safety of oral anticoagulation, the standard preventive medication for ischemic stroke patients with AF, in ICH […]
  Eleni Korompoki
• Timing of oral anticoagulation in acute ischaemic stroke and non-valvular atrial fibrillation: early, 'timely' or late? 2024-12-28
  No abstract
  Ashwin Balu
• Temporal Trends of Ischemic Stroke Risk in Patients With Incident Atrial Fibrillation Before Anticoagulation 2024-12-21
  CONCLUSIONS: The initial IS risk in AF patients, before the initiation of OAC therapy, has decreased by 25% between 2007 and 2018 despite an increase in both age and stroke risk scores. The decrease has been most pronounced in older women with high stroke risk scores.
  Konsta Teppo
• Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 2024-12-20
  CONCLUSIONS: Patients with AF and HF have a high risk of major adverse events, and this risk is inversely associated with LVEF. Atrial Fibrillation Better Care pathway adherent management is associated with improved clinical outcomes in patients with HF, across the spectrum of LVEF.
  Niccolò Bonini
• Association of chronic exercise with markers of cardiometabolic health: a systematic review and meta-analysis 2024-12-20
  CONCLUSIONS: Long-term exercise is linked to a more optimal cardiometabolic profile, although it may not fully replicate the metabolic and cardiovascular health markers observed in younger individuals.
  Nicola Veronese
• Exploring the prognostic impact of triglyceride-glucose index in critically ill patients with first-ever stroke: insights from traditional methods and machine learning-based mortality prediction 2024-12-19
  CONCLUSION: TyG (optimal cut-off: 9.265) was identified as an independent risk factor for ICU and hospital all-cause mortality in first-ever strokes. The ML model incorporating TyG demonstrated strong predictive performance. This emphasises the importance of insulin resistance (with TyG as a surrogate measure) in the prognostic assessment and early risk stratification of first-time stroke patients.
  Yang Chen
• Enhancing stroke risk stratification in atrial fibrillation through non-Newtonian blood modelling and Gaussian process emulation 2024-12-17
  Atrial fibrillation (AF) is the most common heart arrhythmia, linked to a five-fold increase in stroke risk. The left atrial appendage (LAA), prone to blood stasis, is a common thrombus formation site in AF patients. The LAA can be classified into four morphologies: broccoli, cactus, chicken wing and windsock. Stroke risk prediction in AF typically […]
  Paolo Melidoro